News | November 29, 2007

Confirma Previews CAD for Prostate MRI, Introduces New CAD for Breast MRI

December 1, 2007 - Confirma previewed its first version of CADstream improved analysis and reporting for prostate MRI and introduced the next generation of CADstream for breast MRI at RSNA 2007.

The prostate application is designed to offer radiologists comprehensive and clinically valuable tools for improved quality, standardization and efficiency in MRI study analysis and reporting.

The next generation of CADstream for breast MRI, which features a customizable, BI-RADS-centric user interface, improved morphology tools and patient monitoring capabilities.

Additionally, the company previewed the Access Breast Coil, which delivers high-quality diagnostic capability, flexible interventional access and optimized patient comfort.

Prostate MRI is a less invasive procedure using imaging, rather than biopsy first, and enables the physician to target areas of the body more precisely for biopsy planning.

Like Confirma’s CADstream for breast system, CADstream for prostate was designed to provide specific workflow-enhancing tools for prostate MRI analysis and reporting. The system includes image registration, alignment between contrast series and T2 images, and uptake and washout maps. The system also automatically creates multiplanar reformats, subtractions, MIPs and prostate-specific reports.

Acording to A. Joseph Borelli, Jr., M.D., president and medical director, MRI at Belfair in Bluffton, SC, “Prior to CADstream, it took me 45 minutes to interpret a breast MRI, which is now down to an average of 15 minutes. I am seeing similar efficiency improvements with CADstream for prostate.”

CADstream for breast automates analysis, reporting and interventional planning of studies and promotes standardization with the incorporation of the American College of Radiology's Breast Imaging Reporting and Database System (BI-RADS), which guides the breast cancer diagnostic routine and decision-making process. Confirma's next-generation version of CADstream for breast MRI, launched at the RSNA meeting, includes a new customizable BI-RADS-centric user interface that accommodates a variety of user experience levels. Additional CADstream enhancements include therapeutic monitoring capabilities, improved 3D renderings and tools for morphology reporting.

According to Confirma, its Access Breast Coil provides quality diagnostic capability with high signal-to-noise ratio. Its open design performs interventional procedures with both lateral and medial access. Patient comfort is improved with memory foam and positioning accessories for positioning during diagnostic and interventional breast MRI studies.

Source: RSNA

For more information: www.confirma.com

Related Content

Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
Enlitic Closes Series B Funding for Artificial Intelligence Solutions for Radiologists
News | Artificial Intelligence | April 08, 2019
Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round...
iCAD Highlighting ProFound AI for Tomosynthesis at 2019 SBI Annual Symposium
News | Computer-Aided Detection Software | April 04, 2019
iCAD announced it will present its latest artificial intelligence (AI) software solution for digital breast...
A smart algorithm developed by iCAD

A smart algorithm developed by iCAD outlines and scores a suspicious lesion seen in an image created using digital breast tomography. Displayed is the probability calculated by the algorithm that the outlined area includes a cancerous lesion. Image courtesy of Emily Conant, M.D.

Feature | Artificial Intelligence | April 03, 2019 | Greg Freiherr
  Editor's Note: This article was updated following the SBI symposium.  
Siemens Healthineers Debuts AI-Rad Companion Chest CT
News | Artificial Intelligence | January 25, 2019
Siemens Healthineers presented its first intelligent software assistant for radiology, the AI-Rad Companion Chest CT,...
Telerad Tech Launches MammoAssist AI Software
Technology | Computer-Aided Detection Software | January 25, 2019
Telerad Tech recently announced the launch of MammoAssist, a new artificial intelligence (AI) product to analyze and...
Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing...
FDA Clears iCAD's ProFound AI for Digital Breast Tomosynthesis
Technology | Mammography | December 07, 2018
iCAD Inc. announced clearance by the U.S. Food and Drug Administration (FDA) for their latest, deep-learning, cancer...